← Leaderboards
Esra Karakose-Balioglu
Icahn School Of Medicine At Mount Sinai
$860,664
Attributed
$860,664
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $253.5K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$860,664 · 2
By mechanism
K01$607,164 · 1
R03$253,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Robert J Devita$8,217,526
- Peng Wang$1,524,112
- Carmen Argmann$789,913
- Anastasia Efthymiou$131,700
- Sarah Elizabeth Williams$146,206
Research focus
Non-Insulin-Dependent Diabetes MellitusReceptorInsulinMolecularPancreas TransplantationProliferatingDiabetes MellitusExperimental StudyInsulin-Dependent Diabetes MellitusIslets Of Langerhans TransplantationOrgan DonorAgonistPharmaceutical PreparationsPharmacotherapyAffectCostAtac-SeqEpigenetic ProcessChromatinCell ProliferationIsletCellsBeta CellRegenerative
Grant awards (5)
Longitudinal single cell responses in human islet organoids to beta cell regenerative drugs$253,500
R03 · FY2025 · DK · contact PI
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation$151,416
K01 · FY2024 · DK · contact PI
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation$151,416
K01 · FY2023 · DK · contact PI
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation$151,416
K01 · FY2022 · DK · contact PI
Epigenetic regulation in therapeutic human pancreatic beta cell proliferation$152,916
K01 · FY2021 · DK · contact PI